标题
TOP2Agene copy number change in breast cancer
作者
关键词
-
出版物
JOURNAL OF CLINICAL PATHOLOGY
Volume 67, Issue 5, Pages 420-425
出版商
BMJ
发表日期
2014-01-09
DOI
10.1136/jclinpath-2013-202052
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials
- (2013) George Fountzilas et al. BMC CANCER
- Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients
- (2013) M. J. Engstrøm et al. BREAST CANCER RESEARCH AND TREATMENT
- HER2Gene Amplification in Breast Cancer
- (2012) Jane Starczynski et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer
- (2012) Joseph A. Sparano et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic Value of TOP2A Gene Amplification and Chromosome 17 Polysomy in Early Breast Cancer
- (2012) Anna Żaczek et al. PATHOLOGY & ONCOLOGY RESEARCH
- Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization
- (2011) Atocha Romero et al. AMERICAN JOURNAL OF PATHOLOGY
- Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes
- (2011) Zsuzsanna Varga et al. BREAST CANCER RESEARCH AND TREATMENT
- Joint effects of nulliparity and other breast cancer risk factors
- (2011) S Opdahl et al. BRITISH JOURNAL OF CANCER
- HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods
- (2011) J. M. S. Bartlett et al. JOURNAL OF CLINICAL PATHOLOGY
- HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data
- (2011) Angelo Di Leo et al. LANCET ONCOLOGY
- Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status
- (2011) Kirsten Vang Nielsen et al. Molecular Oncology
- Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
- (2009) Guido Sauter et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer
- (2008) A. Rody et al. BREAST CANCER RESEARCH AND TREATMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search